Orthofix Medical (OFIX) Research & Development (2016 - 2025)
Historic Research & Development for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $14.8 million.
- Orthofix Medical's Research & Development fell 1457.15% to $14.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year decrease of 609.14%. This contributed to the annual value of $73.6 million for FY2024, which is 821.13% down from last year.
- Per Orthofix Medical's latest filing, its Research & Development stood at $14.8 million for Q3 2025, which was down 1457.15% from $15.9 million recorded in Q2 2025.
- In the past 5 years, Orthofix Medical's Research & Development ranged from a high of $23.3 million in Q1 2023 and a low of $10.9 million during Q1 2021
- For the 5-year period, Orthofix Medical's Research & Development averaged around $15.9 million, with its median value being $15.9 million (2025).
- Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 10787.55% in 2023, then crashed by 1636.85% in 2024.
- Orthofix Medical's Research & Development (Quarter) stood at $13.2 million in 2021, then fell by 0.69% to $13.2 million in 2022, then skyrocketed by 44.02% to $18.9 million in 2023, then dropped by 0.7% to $18.8 million in 2024, then fell by 21.45% to $14.8 million in 2025.
- Its last three reported values are $14.8 million in Q3 2025, $15.9 million for Q2 2025, and $19.8 million during Q1 2025.